Showing results (1431-1440 of 1,694) with videos related to

Sort By:
Pageof 170
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 23, 2024
Sleep macro-architecture in patients with Parkinson's disease does not change during the first night of neurostimulation in a pilot studyRig Das, Stephen V Gliske, Leslie C West, et al.
The Journal of Experimental Medicine|January 2, 2013
The cell fate determinant Llgl1 influences HSC fitness and prognosis in AMLFlorian H Heidel, Lars Bullinger, Patricia Arreba-Tutusaus, et al.
Plos Biology|March 26, 2013
An abscisic acid-independent oxylipin pathway controls stomatal closure and immune defense in ArabidopsisJean-Luc Montillet, Nathalie Leonhardt, Samuel Mondy, et al.
Journal of Medicinal Chemistry|August 3, 2016
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic PainHerbert H Seltzman, Craig Shiner, Erin E Hirt, et al.
Revue Medicale Suisse|January 22, 2020
[Neurology 2019]Matthieu Perrenoud, Vasiliki Pantazou, Patrik Michel, et al.
Nature Microbiology|October 1, 2025
Structure of a distinct β-barrel assembly machinery complex in the BacteroidotaAugustinas Silale, Mariusz Madej, Katarzyna Mikruta, et al.
Clinical Pharmacology and Therapeutics|May 13, 2020
Maternal Betamethasone for Prevention of Respiratory Distress Syndrome in Neonates: Population Pharmacokinetic and Pharmacodynamic ApproachFrantz Foissac, Yi Zheng, Déborah Hirt, et al.
Transplantation Direct|December 12, 2022
Differences Between Centers in Psychosocial Evaluations for Living Kidney Donors Do Not Influence Outcome: Results From an Observational Multicenter StudyGundula Ludwig, Irene Geiger, Lutz Götzmann, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2)Déborah Hirt, Alain Pruvost, Didier K Ekouévi, et al.
Contemporary Clinical Trials|September 13, 2015
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantationTobias Deuse, Christoph Bara, Markus J Barten, et al.
Pageof 170